Medical Technology Schools reports that with artificial intelligence, pharmaceutical companies can accelerate the drug discovery process, enhance the precision of targeting specific diseases, and significantly reduce the time and cost associated with bringing new medications to the market.
This item is available in full to subscribers.
Please log in to continueNeed an account?
|
Other items that may interest you